These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 4033804)
1. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Clark D; Engberg G; Pileblad E; Svensson TH; Carlsson A; Freeman AS; Bunney BS Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):344-54. PubMed ID: 4033804 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat. Elam M; Clark D; Svensson TH Neuropharmacology; 1986 Sep; 25(9):1003-8. PubMed ID: 3774122 [TBL] [Abstract][Full Text] [Related]
3. Effects of intraperitoneal administration of apomorphine and the isomers of 3-(1-propyl-3-piperidinyl)phenol on the firing activity of substantia nigra dopamine neurons: comparison of agonist efficacies and development of acute tolerance. Meltzer LT; Christoffersen CL Neuropharmacology; 1988 Sep; 27(9):933-42. PubMed ID: 3185867 [TBL] [Abstract][Full Text] [Related]
4. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones. Kelly E; Jenner P; Marsden CD Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS Synapse; 1992 Aug; 11(4):267-78. PubMed ID: 1323882 [TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
7. Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors. Bergstrom DA; Carlson JH; Bromley SD; Jackson DM; Walters JR Eur J Pharmacol; 1986 May; 124(1-2):75-84. PubMed ID: 3720847 [TBL] [Abstract][Full Text] [Related]
8. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Clark D; Hjorth S; Carlsson A J Neural Transm; 1985; 62(1-2):1-52. PubMed ID: 3894582 [TBL] [Abstract][Full Text] [Related]
9. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Clark D; Salah RS; Galloway MP Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667 [TBL] [Abstract][Full Text] [Related]
10. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751 [TBL] [Abstract][Full Text] [Related]
11. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Jeziorski M; White FJ Synapse; 1989; 4(4):267-80. PubMed ID: 2603146 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. Koch SW; Koe BK; Bacopoulos NG Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267 [TBL] [Abstract][Full Text] [Related]
13. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. Clark D; Hjorth S; Carlsson A Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268 [TBL] [Abstract][Full Text] [Related]
14. Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons. Engberg G; Wikström H Eur J Pharmacol; 1991 Aug; 201(2-3):199-202. PubMed ID: 1686758 [TBL] [Abstract][Full Text] [Related]
15. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Hjorth S; Clark D; Carlsson A Life Sci; 1985 Aug; 37(7):673-84. PubMed ID: 2410756 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat. Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Zhang J; Chiodo LA; Freeman AS Synapse; 1993 Dec; 15(4):276-84. PubMed ID: 7908761 [TBL] [Abstract][Full Text] [Related]
18. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro. Mulder AH; Draper R; Sminia P; Schoffelmeer AN; Stoof JC Eur J Pharmacol; 1985 Jan; 107(3):291-7. PubMed ID: 3979429 [TBL] [Abstract][Full Text] [Related]
19. Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat. Hashimoto S; Okuyama S; Aihara H Neuropharmacology; 1987 Jul; 26(7A):663-7. PubMed ID: 2888038 [TBL] [Abstract][Full Text] [Related]
20. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction. Shen RY; Asdourian D; Chiodo LA Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]